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Background: To date, incidence data for kidney failure in Australia have been available for only those who
start renal replacement therapy (RRT). Information about the total incidence of kidney failure, including
non–RRT-treated cases, is important to help understand the burden of kidney failure in the community and the
characteristics of patients who die without receiving treatment.
Study Design: Data linkage study of national observational data sets.
Setting & Participants: All incident treated cases recorded in the Australia and New Zealand Dialysis and
Transplant Registry (ANZDATA) probabilistically linked to incident untreated kidney failure cases derived from
national death registration data for 2003-2007.
Predictor: Age, sex, and year.
Outcomes: Kidney failure, a combination of incident RRT or death attributed to kidney failure (without RRT).
Measurements: Total incidence of kidney failure (treated and untreated) and treatment rates.
Results: There were 21,370 incident cases of kidney failure in 2003-2007. The incidence rate was
20.9/100,000 population (95% CI, 18.3-24.0) and was significantly higher among older people and males
(26.1/100,000 population; 95% CI, 22.5-30.0) compared with females (17.0/100,000 population; 95% CI,
14.9-19.2). There were similars number of treated (10,949) and untreated (10,421) cases, but treatment rates
were influenced highly by age. More than 90% of cases in all age groups between 5 and 60 years were treated,
but this percentage decreased sharply for older people; only 4% of cases in persons 85 years or older were
treated (ORs for no treatment of 115 [95% CI, 118-204] for men 80 years and 400 [95% CI, 301-531] for
women80 years compared with those of the same sex who were50 years).
Limitations: Cross-sectional design, reliance on accurate coding of kidney failure in death registration data.
Conclusions: Almost all Australians who develop kidney failure at younger than 60 years receive RRT, but
treatment rates decrease substantially above that age.
Am J Kidney Dis. xx(x):xxx. © 2012 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights
reserved.
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Chronic kidney disease (CKD), particularly kid-ney failure, imposes a substantial health burden
in the Australian community. It is estimated that 1 in 9
Australian adults older than 25 years have some
degree of CKD.1 CKD contributed to 10% of all
deaths in 20072 and 15% of all hospitalizations in
2009-2010,3 most of which were for maintenance
dialysis. Treatment of CKD accounts for almost 2%
of allocated direct health care expenditures, and these
costs are increasing in magnitude and as a proportion
of total spending.4
To date, incidence data for kidney failure in Austra-
lia and most other countries have been available for
only those who start renal replacement therapy (RRT),
referred to here as “treated” kidney failure. Outcomes
for all patients receiving RRT for whom kidney function
is not anticipated to recover and the intention to treat is
long term are captured by the Australia and New Zea-
land Dialysis and Transplant Registry (ANZDATA).5
Information about the total incidence of kidney fail-
ure, which includes those who die of kidney failure
without long-term commencement of RRT (referred
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to here as untreated kidney failure), is important to
help understand the full burden, as well as the charac-
teristics, of patients who die without receiving treat-
ment, whether by choice or lack of access. Such
information also might help better understand differ-
ences6 in the incidence of RRT between countries.
This study expands on results previously published
in an Australian government report titled End-Stage
Kidney Disease in Australia: Total Incidence 2003-
2007.7 It builds on a method used elsewhere to deter-
mine kidney failure end points in cohort studies.8-10
These studies used data linkage to estimate the num-
ber of people with kidney failure (or CKD more
generally) who did not receive RRT. However, each of
these followed up a particular cohort (eg, the National
Health and Nutrition Examination Survey [NHANES]
in the United States) rather than directly determining
the national incidence.
The aim of this study was to estimate the total inci-
dence of kidney failure in Australia for 2003-2007. This
was done by linking 2 nationwide data collections—
ANZDATA and national mortality data, thereby captur-
ing and allowing analysis of all cases of kidney failure
regardless of whether managed with RRT.
METHODS
Data Set Sources andDeﬁnitions
Kidney failure cases were identified from 2 different data
sources. The first was ANZDATA. The second was the Australian
Institute of Health and Welfare National Mortality Database,
which includes cause of death and demographic information for all
deaths registered in Australia starting in 1965. A third data source,
the National Death Index, was used in the linkage process to
determine the overlap between the 2 main data sources, described
later.
An incident case was defined as a case newly registered on
ANZDATA in 2003-2007 (treated kidney failure) or a death
registered in 2003-2007 with kidney failure recorded as a cause,
but which was not recorded in ANZDATA (untreated kidney
failure).
Kidney failure in mortality data was defined as chronic renal
failure (International Classification of Diseases, Tenth Revision
[ICD-10] codes N18.0, N18.8, and N18.9), hypertensive renal
failure (ICD-10 codes I12.0, I13.1, and I13.2), or unspecified renal
failure (ICD-10 code N19) as an underlying cause of death, or
chronic renal failure, end-stage (ICD-10 code N18.0), as an associ-
ated cause of death. The underlying cause of death refers to the
condition that started the course of events leading directly to a
person’s death. The associated cause of death refers to any other
condition thought to have contributed to the death. Mortality data
were used to estimate the incidence of untreated cases because by
definition, people with kidney failure show signs or symptoms of
kidney failure to the extent that they require RRT,11 and survival
for those who do not receive RRT is likely to be short.12-14 Thus,
year of death can be used as a proxy for incidence year.
To avoid double counting, ANZDATA was linked to the Na-
tional Death Index using probabilistic linkage based on identifying
information, including date of birth, name, sex, date of death, and
postal code of residence. ANZDATA cases used in the linkage
process were all patients receiving treatment in Australia between
2003 and 2007 (regardless of when treatment began), as well as
any cases of patients lost to follow-up, to make certain that cases of
kidney failure in the mortality data were not mistakenly assigned
to the untreated group. These data then were linked to National
Mortality Database data (which can be linked to National Death
Index data through a unique identifier). If cases were present in
both ANZDATA and National Mortality Database data, they were
counted only once as treated cases. Approval for the data linkage
and analysis was obtained through the Australian Institute of
Health and Welfare Ethics Committee.
Statistical Analysis
Total incidence rates were analyzed using Poisson regression, with
year, age (in 5-year groupings), and sex as covariates. Interaction
between age group and sex and between age group and year also were
tested for significance using type  analysis.15 Denominator popula-
tion data came from the Estimated Resident Population series pro-
duced by the Australian Bureau of Statistics.16
Logistic regression analysis was used to examine treatment rates
with RRT. For this, the relationship between year, age group, and
sex and the probability of no treatment was assessed. Because of
the small number of cases in persons younger than 50 years, age
groups were set as those younger than 50 years and then 5-year age
groups up to 80 years or older. The interaction between age group
and sex also was taken into consideration in the model. Hosmer-
Lemeshow test and C statistic were used to assess goodness of fit.
P 0.05 was considered statistically significant for main effects
and interactions. All analyses were done using SAS Enterprise
Guide, version 4.3 (SAS Institute Inc).
RESULTS
Total Incidence
There were 21,370 incident cases of kidney failure
in 2003-2007, comprising 10,949 treated cases and
10,421 untreated cases. The overall incidence rate was
20.9/100,000 population (95% confidence interval
[CI], 18.3-24.0). The incidence rate increased substan-
tially with age, particularly among those older than 70
years, with 63% of all new cases being individuals 70
years or older. The age-adjusted total incidence was
higher for males than females (26.1/100,000 popula-
tion [95% CI, 22.5-30.0] vs 17.0/100,000 population
[95% CI, 14.9-19.2]); however, this sex difference
was not apparent at younger than 40 years (Table 1).
TreatmentRates
Overall, there were similar numbers of treated and
untreated cases. However, this varied greatly with
age. A very high proportion of cases in younger
people were treated:90% in all age groups between
5 and 60 years. The percentage treated decreased
sharply in older people, with only 4% of new cases of
persons 85 years or older treated (Figs 1-3).
Logistic regression confirmed that treatment rates
were influenced highly by age. The odds of not
receiving treatment increased sharply with age (Table
2). Sex also was associated with different treatment
proportions among older age groups, in which men
(aged 75 years) were more likely to be receiving
Am J Kidney Dis. 2012;xx(x):xxx2
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treatment than their female counterparts. For the 5-year
period used in this study, year did not affect treatment
rates and was removed from the final model to derive
parameter estimates.
SensitivityAnalyses
Total numbers were recalculated excluding untreated
cases for which chronic renal failure, end-stage (ICD-10
code N18.0), was recorded as an associated cause of
death. The total number of cases decreased by 4.5% to
20,408 when these cases were excluded, which equated
9,459 untreated and 10,949 treated.
DISCUSSION
In this study, we found that in 2003-2007, the
number of incident cases of kidney failure in Australia
was twice as many as those recorded as receiving
treatment. Total incidence was higher for older people
and men. Most untreated cases were people older than
60 years, and women older than 75 years were less
likely to receive treatment than men.
The most striking implication from this study is the
substantial number of people older than 60 years who
died with kidney failure, but were not treated with
Table 1. Total Incidence of Kidney Failure in Australia, 2003-2007
Age Group (y) Incident Cases Populationa
Incidence Rate/100,000 Population (95% CI)
Males Females
0-4 36 6,484,292 0.8 (0.5-1.1) 0.3 (0.2-0.6)
5-9 46 6,698,649 0.8 (0.5-1.1) 0.6 (0.4-1.0)
10-14 45 6,982,321 0.5 (0.3-0.8) 0.8 (0.5-1.1)
15-19 103 7,024,408 1.6 (1.3-2.1) 1.3 (1.0-1.7)
20-24 156 6,955,491 2.7 (2.2-3.3) 1.8 (1.4-2.3)
25-29 251 7,182,535 4.0 (3.4-4.7) 3.0 (2.5-3.6)
30-34 330 7,527,028 4.8 (4.1-5.6) 4.0 (3.4-4.7)
35-39 461 7,505,170 7.4 (6.5-8.3) 5.0 (4.3-5.7)
40-44 660 7,674,235 10.4 (9.4-11.5) 6.8 (6.0-7.7)
45-49 819 7,326,397 13.7 (12.5-15.0) 8.7 (7.8-9.8)
50-54 980 6,717,716 18.5 (17.0-20.1) 10.8 (9.7-12.0)
55-59 1,224 6,131,134 23.6 (21.9-25.5) 16.3 (14.8-17.8)
60-64 1,274 4,770,305 32.1 (29.8-34.7) 21.2 (19.4-23.3)
65-69 1,586 3,808,303 49.8 (46.4-53.4) 33.7 (31.1-36.6)
70-74 2,046 3,159,318 80.6 (75.8-85.8) 50.1 (46.6-53.9)
75-79 2,716 2,735,712 127.5 (120.6-134.9) 75.8 (71.1-80.8)
80-84 3,095 1,965,117 216.1 (204.7-228.1) 117.5 (110.8-124.7)
85 5,542 1,539,790 447.3 (425.7-470.0) 318.7 (305.3-332.8)
Total 21,370 102,187,921 26.1 (22.5-30.0) 17.0 (14.9-19.2)
Note: Total rates are adjusted for age.
Abbreviation: CI, confidence interval.
aFive-year population at risk.
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Figure 1. Age-specific renal replace-
ment therapy treatment rates, 2003-2007.
aRates are predicted. Adapted and repro-
duced from Australian Institute of Health and
Welfare (AIHW)7 with permission of the
AIHW.
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RRT. This is similar to trends reported by others.9,17
There also was a small number of patients (n  250)
younger than 60 years who were not treated with RRT.
The data available in this analysis do not provide
sufficient information about the whole patient profile
to provide answers about why some people do not
receive RRT. However, there could be a number of
reasons. Known factors that could be operating in
these older cohorts include late referral, medical co-
morbid conditions, overall quality of life, and total
functional capacity.18-20 In the Caring for Austral-
asians With Renal Impairment guidelines,21 it is rec-
ommended that patients with an estimated glomerular
filtration rate (eGFR) 30 mL/min/1.73 m2 (CKD
stage 4) be referred to a nephrology service to give
adequate time to prepare for RRT or supportive man-
agement and palliative care.22 A retrospective study of
patients with CKD stages 3 and 4 in the United States
referred to a nephrology service compared with those
who were stage 4 CKD and not referred found that
elderly and female patients were less likely to be
referred.23 In addition, for elderly patients, greater
comorbidity was a predictor of nonreferral. In a single-
center study of patients 80 years or older, patients not
offered dialysis were more likely to be referred late,
be socially isolated, have diabetes, and have greater
functional impairment.14
A recent study from Canada assessed rates of treated
and untreated kidney failure in older versus younger
adults.17 In a cohort of more than 1.8 million adults
who had a baseline eGFR recorded in outpatient data
between 2002 and 2008, they found results similar to
those in our study: rates of untreated kidney failure
were significantly higher in older adults compared
with younger adults. Unlike our study, which defines
untreated kidney failure as death attributed to kidney
failure in death certificates, that group defined kidney
failure as eGFR15 mL/min/1.73 m2. There is likely
to be a considerable lag in many cases between people
achieving eGFR 15 mL/min/1.73 m2 and death. It
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Figure 2. Number of treated and un-
treated cases, by age group at kidney failure
onset, 2003-2007. Adapted and reproduced
from Australian Institute of Health and Wel-
fare (AIHW)7 with permission of the AIHW.
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Figure 3. Proportion of all cases that are
treated, by age group at kidney failure onset
and sex, 2003-2007.
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also is probable that a proportion of these people will
not have died of kidney failure, suggesting that the
Canadian study is likely to count more untreated cases
than our study.
There could be a number of potential explanations
of why women from age 75 years were less likely to
be treated than men. These include reasons related to
social support and the caring role often played by
spouses. In Australia, more women than men 65 years
and older are living alone, influenced by a longer life
expectancy in women and a higher number of widows
than widowers.24
The decision to undertake dialysis or transplanta-
tion treatment or rely on symptom control and pallia-
tion is one taken by an individual in consultation with
his or her family and medical advisors. In Australia,
there are no regulations governing entitlement to (or
denial of) dialysis treatment. This judgment likely
will depend on a number of factors evaluated by the
individual and his or her medical advisor. There is a
lack of research regarding this decision-making pro-
cess; however, factors may include perceptions of the
efficacy of dialysis treatment and the burden that
treatment imposes on quality of life, as well as the
relative outcomes of dialysis versus no dialysis. Our
finding of a large number of untreated cases suggests
there is a need to understand whether this decision-
making process is undertaken appropriately in all
cases and whether there are barriers to accessing
treatment, such as for people not living close to
available dialysis services.
The large number of untreated cases also indicates
a potential group that may be interested in receiving
treatment, if services were available and acceptable.
There have been many changes in medical care for
older patients during the last 5-10 years. For this
reason, it is not surprising that more older patients are
now receiving active therapy than was the case previ-
ously.25 It is possible that if dialysis outcomes im-
prove or attitudes change in the future, the proportion
and number of patients seeking treatment may con-
tinue to increase. It is important for planning of RRT
services that these trends are monitored, understood,
and predicted.
There are known differences in total incidence rates
among population groups, including by indigenous
status, remoteness areas, and socioeconomic groups.7
However, due to limitations in data quality, these
variables could not be included in the modeling in this
study.
International comparisons of the incidence of RRT
show a large variation in rates among comparable
countries.6,26,27 Australian incident RRT rates are sub-
stantially lower than those of white US citizens and
modestly lower than those of most European coun-
tries.27 Higher rates of treated RRT, such as in the
United States, might be explained by a greater propen-
sity to provide RRT to older people or higher rates of
risk factors such as diabetes.26 Comparisons of age-
specific incident RRT rates show that for people 75
years and older, the rate of treated kidney failure in the
United States is 4 times the Australian rate.5,27 This
decreases to approximately 3.4 times the rate when
including only US whites. In comparison, the United
Kingdom and Australia have similar overall RRT
rates,26 but there are differences between 55 and 79
years of age, with Australian RRT rates being 20%
higher.5,28 Given the standard use of ICD coding on
death certifications throughout the world, the method-
ology used here could be replicated in countries with
national renal registries and the ability to link these to
death records. This could help examine the extent to
which incidence rates are influenced by the propensity
to treat older patients.
To our knowledge, this is the first study to estimate
the total incidence of kidney failure for a country.
Others have used a similar method of data linkage to
establish the number of people with kidney failure
Table 2. Probability of No Treatment
Age Group (y)
Females Males
OR (95% CI) P OR (95% CI) P
50 1.0 (reference) 0.8 (0.5-1.2) 0.2
50-54 1.9 (1.2-3.1) 0.01 1.5 (1.0-2.4) 0.06
55-59 2.6 (1.7-3.9) 0.001 2.7 (1.8-3.8) 0.001
60-64 2.9 (1.9-4.3) 0.001 3.9 (2.8-5.4) 0.001
65-69 5.9 (4.3-8.2) 0.001 7.7 (5.7-10.5) 0.001
70-74 13.0 (9.6-17.5) 0.001 11.7 (8.8-15.6) 0.001
75-79 33.2 (25.0-44.2) 0.001 25.7 (19.5-33.9) 0.001
80 399.9 (301.0-531.3) 0.001 155.5 (118.2-204.4) 0.001
Note: 2 633.7429 (P 0.001).
Abbreviations: CI, confidence interval; OR, odds ratio.
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who are not given RRT,8-10,29 but in the context of a
cohort follow-up instead of directly determining the
total incidence in a country. The ICD codes for cause
of death used here also differ somewhat from those
used in the other studies, with the present study
including only kidney failure rather than earlier stages
of CKD.
There is some evidence that the choice of codes for
cause of death in this study may be conservative and
underestimate the number of untreated cases of kid-
ney failure because not all people dying with treated
kidney failure had it recorded on their death certifi-
cates. For the individuals in this study who started
treatment between 2003 and 2007 and died during that
period, only 44% had kidney failure (as defined in this
study) recorded on their death certificate.7 A further
44% had other CKD codes recorded on their death
certificates, with the remaining 12% having no record
of CKD contributing to their death. If the same trend
applied to the untreated cases, there would be many
more cases than we currently count.
It also is possible that our method may include
some untreated cases of persons who had reduced
kidney function, but not yet to the degree that necessi-
tated the initiation of dialysis therapy or transplanta-
tion. However, this probably pertains to only the fairly
small proportion of cases included because they had
an associated cause of death of chronic renal failure,
end-stage (ICD-10 code N18.0), and were not treated
with RRT. Removing these cases reduced the total
incidence estimates by 4.5%. In the remaining un-
treated cases, renal failure was the underlying cause
of death, so they were included. For these cases, it is
sensible to suppose that because the disease was
severe enough to start the course of events that led
directly to the death, it was severe enough be classi-
fied as kidney failure.
Counting the untreated cases relies on kidney fail-
ure having been recorded correctly in national mortal-
ity data and in such a way that CKD is distinguished
from it more broadly. There are standard definitions
and rules used to record and code causes of death in
Australia30 that promote consistency. However, there
may still be a level of inaccuracy. Two studies have
compared the cause of death of patients with kidney
failure on death certificates with another source of
data about deaths, one from Australia and one from
the United States.31,32 Both of these showed wide
disparity in agreement between the data sources being
compared, depending on the cause of death, although
neither compared death certificate data with clinical
records, which would be the preferred approach. The
Australian study compared ANZDATA with the Na-
tional Mortality Database in terms of causes of death;
agreement ranged from poor (genitourinary diseases)
to good (cancer). A wide variety of factors may
complicate the comparison between the 2 data
sources,33 including the ANZDATA cause of death
data not being based on ICD-10 coding, and thus
comparability is limited.
Further development of the method used to count
the untreated cases is key. One approach is to link the
current data set with national hospital data. This
would identify untreated cases in which the individual
is still living. Furthermore, it would give useful infor-
mation about how the coding in hospitals and deaths
databases compare, which could give information to
improve the accuracy of the incidence estimates.
Another option that may help refine the current mea-
sure is a validation study of the mortality data, cover-
ing both the accuracy of the death certificate and the
coding of that information using the ICD.
The creation of the data set described in this analy-
sis, which includes both treated and untreated cases,
has greatly heightened our understanding of the total
incidence of kidney failure, the divide between treated
and untreated cases, and differing patterns by age and
sex. This new method of counting will be developed
and investigated further in the future.
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